Skip to main content
Erschienen in: Lasers in Medical Science 3/2021

19.08.2020 | Original Article

Effects of photobiomodulation on cellular viability and cancer stem cell phenotype in oral squamous cell carcinoma

verfasst von: Ana Melissa Ccopa Ibarra, Mônica Pereira Garcia, Marlene Ferreira, Daniela de Fátima Teixeira da Silva, Christiane Pavani, Raquel Agnelli Mesquita-Ferrari, Kristianne Porta Santos Fernandes, Fabio Daumas Nunes, Maria Fernanda Setúbal Destro Rodrigues

Erschienen in: Lasers in Medical Science | Ausgabe 3/2021

Einloggen, um Zugang zu erhalten

Abstract

Oral squamous cell carcinoma (OSCC) is the most common head and neck malignancy; it has been shown that cancer stem cells (CSC) are present in OSCC and associated with tumor growth, invasion, metastasis, and therapeutic resistance. Photobiomodulation (PBM) is an alternative tool for oncologic treatment adverse effects such as oral mucositis (OM); however, controversy exists regarding the undesirable effects of PBM on tumor or CSC. This study aimed to evaluate in vitro, the effects of PBM, with the same dosimetric parameters as those used in the clinic for OM prevention and treatment, on OSCC cellular viability, as well as PBM’s effect on CSC properties and its phenotype. OSCC cell lines were submitted to single or daily PBM with 3 J/cm2 and 6 J/cm2 and then the cellular viability was evaluated by MTT, NRU (neutral red uptake), and CVS (crystal violet staining). The CSC populations were evaluated by clonogenic formation assay, flow cytometry, and RT-qPCR. The single PBM with the 3 J/cm2 group was associated with increased cellular viability. Daily PBM with 3 J/cm2 and 6 J/cm2 was associated with a significant decrease in cellular viability. Additionally, daily PBM was not able to promote CSC self-renewal or the CD44high/ESAlow and CD44high/ESAhigh cellular phenotypes. Moreover, a decrease in the number of spheres and in the expression of the CSC related gene BMI1 was observed after daily PBM with 6 J/cm2. Daily PBM with 3 J/cm2 and 6 J/cm2 showed an inhibitory effect on cellular viability and was not able to promote the CSC self-renewal or phenotype.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
6.
Zurück zum Zitat Prince ME, Sivanandan R, Kaczorowski A, Wolf GT, Kaplan MJ, Dalerba P, Weissman IL, Clarke MF, Ailles LE (2007) Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. J Proc Natl Acad Sci 104:973–978. https://doi.org/10.1073/pnas.0610117104CrossRef Prince ME, Sivanandan R, Kaczorowski A, Wolf GT, Kaplan MJ, Dalerba P, Weissman IL, Clarke MF, Ailles LE (2007) Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. J Proc Natl Acad Sci 104:973–978. https://​doi.​org/​10.​1073/​pnas.​0610117104CrossRef
8.
Zurück zum Zitat Rodrigues MFSD, Xavier FCDA, Andrade NP, Lopes C, Miguita Luiz L, Sedassari BT, Ibarra AMC, López RVM, Kliemann Schmerling C, Moyses RA, Tajara da Silva EE, Nunes FD (2018) Prognostic implications of CD44, NANOG, OCT4, and BMI1 expression in tongue squamous cell carcinoma. Head Neck 40:1759–1773. https://doi.org/10.1002/hed.25158CrossRefPubMed Rodrigues MFSD, Xavier FCDA, Andrade NP, Lopes C, Miguita Luiz L, Sedassari BT, Ibarra AMC, López RVM, Kliemann Schmerling C, Moyses RA, Tajara da Silva EE, Nunes FD (2018) Prognostic implications of CD44, NANOG, OCT4, and BMI1 expression in tongue squamous cell carcinoma. Head Neck 40:1759–1773. https://​doi.​org/​10.​1002/​hed.​25158CrossRefPubMed
13.
Zurück zum Zitat De Sanctis V, Bossi P, Sanguineti G, Trippa F, Ferrari D, Bacigalupo A, Ripamonti CI, Buglione M, Pergolizzi S, Langendjik JA, Murphy B, Raber-Durlacher J, Russi EG, Lalla RV (2016) Mucositis in head and neck cancer patients treated with radiotherapy and systemic therapies: literature review and consensus statements. Crit Rev Oncol Hematol 100:147–166. https://doi.org/10.1016/j.critrevonc.2016.01.010CrossRef De Sanctis V, Bossi P, Sanguineti G, Trippa F, Ferrari D, Bacigalupo A, Ripamonti CI, Buglione M, Pergolizzi S, Langendjik JA, Murphy B, Raber-Durlacher J, Russi EG, Lalla RV (2016) Mucositis in head and neck cancer patients treated with radiotherapy and systemic therapies: literature review and consensus statements. Crit Rev Oncol Hematol 100:147–166. https://​doi.​org/​10.​1016/​j.​critrevonc.​2016.​01.​010CrossRef
14.
Zurück zum Zitat Lalla RV, Bowen J, Barasch A, Elting L, Epstein J, Keefe DM, McGuire DB, Migliorati C, Nicolatou-Galitis O, Peterson DE, Raber-Durlacher JE, Sonis ST, Elad S, Cancer TMGLGotMAoSCi and Oncology. ISoO (2014) MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer Metastasis Rev 120:1453–1461. https://doi.org/10.1002/cncr.28592CrossRef Lalla RV, Bowen J, Barasch A, Elting L, Epstein J, Keefe DM, McGuire DB, Migliorati C, Nicolatou-Galitis O, Peterson DE, Raber-Durlacher JE, Sonis ST, Elad S, Cancer TMGLGotMAoSCi and Oncology. ISoO (2014) MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer Metastasis Rev 120:1453–1461. https://​doi.​org/​10.​1002/​cncr.​28592CrossRef
16.
Zurück zum Zitat Zecha JAEM, Raber-Durlacher JE, Nair RG, Epstein JB, Elad S, Hamblin MR, Barasch A, Migliorati CA, Milstein DMJ, Genot M-T, Lansaat L, van der Brink R, Arnabat-Dominguez J, van der Molen L, Jacobi I, van Diessen J, de Lange J, Smeele LE, Schubert MM, Bensadoun R-J (2016) Low-level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: part 2: proposed applications and treatment protocols. J Support Care Cancer 24:2793–2805. https://doi.org/10.1007/s00520-016-3153-yCrossRef Zecha JAEM, Raber-Durlacher JE, Nair RG, Epstein JB, Elad S, Hamblin MR, Barasch A, Migliorati CA, Milstein DMJ, Genot M-T, Lansaat L, van der Brink R, Arnabat-Dominguez J, van der Molen L, Jacobi I, van Diessen J, de Lange J, Smeele LE, Schubert MM, Bensadoun R-J (2016) Low-level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: part 2: proposed applications and treatment protocols. J Support Care Cancer 24:2793–2805. https://​doi.​org/​10.​1007/​s00520-016-3153-yCrossRef
18.
Zurück zum Zitat Zadik Y, Arany PR, Fregnani ER, Bossi P, Antunes HS, Bensadoun RJ, Gueiros LA, Majorana A, Nair RG, Ranna V, Tissing WJE, Vaddi A, Lubart R, Migliorati CA, Lalla RV, Cheng KKF, Elad S (2019) Systematic review of photobiomodulation for the management of oral mucositis in cancer patients and clinical practice guidelines. Support Care Cancer 27:3969–3983. https://doi.org/10.1007/s00520-019-04890-2CrossRef Zadik Y, Arany PR, Fregnani ER, Bossi P, Antunes HS, Bensadoun RJ, Gueiros LA, Majorana A, Nair RG, Ranna V, Tissing WJE, Vaddi A, Lubart R, Migliorati CA, Lalla RV, Cheng KKF, Elad S (2019) Systematic review of photobiomodulation for the management of oral mucositis in cancer patients and clinical practice guidelines. Support Care Cancer 27:3969–3983. https://​doi.​org/​10.​1007/​s00520-019-04890-2CrossRef
22.
25.
Zurück zum Zitat Schalch TD, Fernandes MH, Destro Rodrigues MFS, Guimarães DM, Nunes FD, Rodrigues JC, Garcia MP, Mesquita Ferrari RA, Bussadori SK, Fernandes KPS (2019) Photobiomodulation is associated with a decrease in cell viability and migration in oral squamous cell carcinoma. Lasers Med Sci 34:629–636. https://doi.org/10.1007/s10103-018-2640-4CrossRefPubMed Schalch TD, Fernandes MH, Destro Rodrigues MFS, Guimarães DM, Nunes FD, Rodrigues JC, Garcia MP, Mesquita Ferrari RA, Bussadori SK, Fernandes KPS (2019) Photobiomodulation is associated with a decrease in cell viability and migration in oral squamous cell carcinoma. Lasers Med Sci 34:629–636. https://​doi.​org/​10.​1007/​s10103-018-2640-4CrossRefPubMed
27.
Zurück zum Zitat de Pauli PM, Araújo ALD, Arboleda LPA, Palmier NR, Fonsêca JM, Gomes-Silva W, Madrid-Troconis CC, Silveira FM, Martins MD, Faria KM, Ribeiro ACP, Brandão TB, Lopes MA, Leme AFP, Migliorati CA, Santos-Silva AR (2019) Tumor safety and side effects of photobiomodulation therapy used for prevention and management of cancer treatment toxicities. A systematic review. Oral Oncol 93:21–28. https://doi.org/10.1016/j.oraloncology.2019.04.004CrossRef de Pauli PM, Araújo ALD, Arboleda LPA, Palmier NR, Fonsêca JM, Gomes-Silva W, Madrid-Troconis CC, Silveira FM, Martins MD, Faria KM, Ribeiro ACP, Brandão TB, Lopes MA, Leme AFP, Migliorati CA, Santos-Silva AR (2019) Tumor safety and side effects of photobiomodulation therapy used for prevention and management of cancer treatment toxicities. A systematic review. Oral Oncol 93:21–28. https://​doi.​org/​10.​1016/​j.​oraloncology.​2019.​04.​004CrossRef
Metadaten
Titel
Effects of photobiomodulation on cellular viability and cancer stem cell phenotype in oral squamous cell carcinoma
verfasst von
Ana Melissa Ccopa Ibarra
Mônica Pereira Garcia
Marlene Ferreira
Daniela de Fátima Teixeira da Silva
Christiane Pavani
Raquel Agnelli Mesquita-Ferrari
Kristianne Porta Santos Fernandes
Fabio Daumas Nunes
Maria Fernanda Setúbal Destro Rodrigues
Publikationsdatum
19.08.2020
Verlag
Springer London
Erschienen in
Lasers in Medical Science / Ausgabe 3/2021
Print ISSN: 0268-8921
Elektronische ISSN: 1435-604X
DOI
https://doi.org/10.1007/s10103-020-03131-x

Weitere Artikel der Ausgabe 3/2021

Lasers in Medical Science 3/2021 Zur Ausgabe